100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Previously searched by you
Previously searched by you
logo
Test Bank For Pharmacology Clear and Simple A Guide to Drug Classifications and Dosage Calculations 4th Edition Watkins CA$11.51   Add to cart
Quickly navigate to
Preview
  2.  
  3. Nursing Pharmacology
  4.  
  5. Nursing pharmacology

Exam (elaborations)

Test Bank For Pharmacology Clear and Simple A Guide to Drug Classifications and Dosage Calculations 4th Edition Watkins

1 review
 13 views  0 purchase
  • Course
  • Nursing pharmacology
  • Institution
  • Nursing Pharmacology
  • Book
  • Pharmacology Clear & Simple

Test Bank For Pharmacology Clear and Simple A Guide to Drug Classifications and Dosage Calculations 4th Edition Watkins

Preview 4 out of 136  pages

Document information

  • June 7, 2024
  • 136
  • 2023/2024
  • Exam (elaborations)
  • Questions & answers

Subjects

  • test bank for pharmacology clear and simple a guid

Connected book

book image

Book Title:

Author(s):

  • Edition:
  • ISBN:
  • Edition:

More summaries for

  • Test Bank - Pharmacology Clear and Simple: A Guide to Drug Classifications and Dosage Calculations, 4th Edition (Watkins, 2022), Chapter 1-21 | All Chapters | Latest Edition; Complete Guide.
  • TEST BANK FOR PHARMACOLOGY CLEAR AND SIMPLE 3RD EDITION BY WATKINS ALL CHAPTERS WITH ANSWERS AND RATIONALES
  • TEST BANK - Watkins, Pharmacology Clear and Simple A Guide to Drug Classifications and Dosage Calculations 4th Edition All Chapters 1 - 21
All for this textbook (143)

Written for

  • Nursing pharmacology
  • Nursing pharmacology

1  review

review-writer-avatar

By: alex71 • 3 months ago

Seller

avatar-seller
stuuviaa

Reviews received

Content preview

4
Contents

Chapter Pages
(1) GENERAL PRINCIPLES OF PHARMACOLOGY............................................................................................... 5
PART I PHARMACOKINETICS ........................................................................................................................................ 5
PART II PHARMACODYNAMICS.................................................................................................................................... 8
(2) AGENTS, CONTROLLING THE FUNCTIONS OF THE PERIPHERAL NERVOUS SYSTEM ................. 12
PART I LOCAL ANESTHETICS .............................................................................................................................................. 12
PART II CHOLINOMIMETIC DRUGS ...................................................................................................................................... 16
PART III CHOLINORECEPTOR BLOCKING DRUGS ................................................................................................................. 19
PART IV ADRENORECEPTOR ACTIVATING DRUGS ............................................................................................................... 24
PART V ADRENORECEPTOR ANTAGONIST DRUGS ............................................................................................................... 29
(3) AGENTS, CONTROLLING THE FUNCTIONS OF THE CENTRAL NERVOUS SYSTEM........................ 34
PART I HYPNOTIC DRUGS ................................................................................................................................................... 34
PART II ANTISEIZURE DRUGS ............................................................................................................................................. 38
PART III ANTIPARKINSONIAN AGENTS................................................................................................................................ 41
PART IV ETHYL ALCOHOL .................................................................................................................................................. 44
PART V NARCOTIC ANALGESICS......................................................................................................................................... 46
PART VI NON-NARCOTIC ANALGESICS ............................................................................................................................... 49
PART VII ANTIPSYCHOTIC AGENTS .................................................................................................................................... 51
PART VIII ANTIDEPRESSANT AGENTS ................................................................................................................................ 54
PART IX ANXIOLYTIC AGENTS ........................................................................................................................................... 57
PART X CNS STIMULANTS ................................................................................................................................................. 60
PART XI DRUGS OF ABUSE ................................................................................................................................................. 63
PART XII GENERAL ANESTHETICS ...................................................................................................................................... 65
(4) ORGANOTROPIC AGENTS.................................................................................................................................. 68
PART I DRUGS ACTING ON RESPIRATORY SYSTEM .............................................................................................................. 68
PART II DRUGS USED IN GASTROINTESTINAL DISEASES ...................................................................................................... 70
PART III DRUGS ACTING ON HEMATOPOIETIC SYSTEM........................................................................................................ 73
PART IV DRUGS USED IN DISORDERS OF COAGULATION ..................................................................................................... 74
PART V DRUGS USED FOR TREATMENT OF HEART FAILURE ................................................................................................ 76
PART VI ANTIARRHYTHMIC AGENTS .................................................................................................................................. 78
PART VII DRUGS FOR ANGINA PECTORIS TREATMENT ....................................................................................................... 80
PART VIII ANTIHYPERTENSIVE DRUGS............................................................................................................................... 83
PART IX HYPERTENSIVE (ANTI-HYPOTENSIVE) DRUGS. DRUGS INFLUENCING CEREBRAL BLOOD FLOW. ANTI-MIGRAINE
AGENTS ................................................................................................................................................................................ 85

(5) METABOLIC PROFILE DRUGS .......................................................................................................................... 88
PART I HYPOTHALAMIC & PITUITARY HORMONES, THYROID & ANTITHYROID DRUGS ..................................................... 88
PART II PANCREATIC HORMONES & ANTIDIABETIC DRUGS ............................................................................................... 91
PART III THE GONADAL HORMONES & INHIBITORS ........................................................................................................... 93
PART IV GLUCOCORTICOID, STEROIDAL & NONSTEROIDAL ANTI-INFLAMMATORY DRUGS .............................................. 95
PART V IMMUNOTROPIC & ANTIALLERGIC AGENTS .......................................................................................................... 98
PART VI VITAMINS, VITAMIN-LIKE COMPOUNDS, ANTIVITAMINS, ENZYMES & ANTIENZYMES ...................................... 104
PART VII ANTIHYPERLIPIDEMIC DRUGS & DRUGS USED IN THE TREATMENT OF GOUT .................................................. 110
PART VIII AGENTS THAT AFFECT BONE MINERAL HOMEOSTASIS .................................................................................. 114
PART IX MINERALOCORTICOID, MINERALOCORTICOID ANTAGONISTS, DIURETICS, PLASMA EXPANDERS ...................... 120
(6) CHEMOTHERAPEUTIC DRUGS....................................................................................................................... 124
PART I ANTIBIOTICS .................................................................................................................................................... 124
PART II SYNTHETIC ANTIBACTERIAL DRUGS ....................................................................................................... 129
PART III ANTIPROTOZOAL AND ANTHELMINTIC DRUGS................................................................................... 132
PART IV ANTIVIRAL AGENTS. AGENTS FOR CHEMOTHERAPY OF CANCER .................................................. 135

, 5
(1) GENERAL PRINCIPLES OF PHARMACOLOGY

PART I PHARMACOKINETICS
001. Pharmacokinetics is:
a) The study of biological and therapeutic effects of drugs
b) The study of absorption, distribution, metabolism and excretion of drugs
c) The study of mechanisms of drug action
d) The study of methods of new drug development
002. What does “pharmacokinetics” include?
a) Complications of drug therapy
b) Drug biotransformation in the organism
c) Influence of drugs on metabolism processes
d) Influence of drugs on genes
002. What does “pharmacokinetics” include?
a) Pharmacological effects of drugs
b) Unwanted effects of drugs
c) Chemical structure of a medicinal agent
d) Distribution of drugs in the organism
003. What does “pharmacokinetics” include?
a) Localization of drug action
b) Mechanisms of drug action
c) Excretion of substances
d) Interaction of substances
004. The main mechanism of most drugs absorption in GI tract is:
a) Active transport (carrier-mediated diffusion)
b) Filtration (aqueous diffusion)
c) Endocytosis and exocytosis
d) Passive diffusion (lipid diffusion)
005. What kind of substances can’t permeate membranes by passive diffusion?
a) Lipid-soluble
b) Non-ionized substances
c) Hydrophobic substances
d) Hydrophilic substances
006. A hydrophilic medicinal agent has the following property:
a) Low ability to penetrate through the cell membrane lipids
b) Penetrate through membranes by means of endocytosis
c) Easy permeation through the blood-brain barrier
d) High reabsorption in renal tubules
007. What is implied by «active transport»?
a) Transport of drugs trough a membrane by means of diffusion
b) Transport without energy consumption
c) Engulf of drug by a cell membrane with a new vesicle formation
d) Transport against concentration gradient
008. What does the term “bioavailability” mean?
a) Plasma protein binding degree of substance
b) Permeability through the brain-blood barrier
c) Fraction of an uncharged drug reaching the systemic circulation following any route administration
d) Amount of a substance in urine relative to the initial doze
009. The reasons determing bioavailability are:
a) Rheological parameters of blood
b) Amount of a substance obtained orally and quantity of intakes
c) Extent of absorption and hepatic first-pass effect
d) Glomerular filtration rate
010. Pick out the appropriate alimentary route of administration when passage of drugs through liver is minimized:
a) Oral
b) Transdermal
c) Rectal
d) Intraduodenal
011. Which route of drug administration is most likely to lead to the first-pass effect?
a) Sublingual

, 6
b) Oral
c) Intravenous
d) Intramuscular
012. What is characteristic of the oral route?
a) Fast onset of effect
b) Absorption depends on GI tract secretion and motor function
c) A drug reaches the blood passing the liver
d) The sterilization of medicinal forms is obligatory
013. Tick the feature of the sublingual route:
a) Pretty fast absorption
b) A drug is exposed to gastric secretion
c) A drug is exposed more prominent liver metabolism
d) A drug can be administrated in a variety of doses
014. Pick out the parenteral route of medicinal agent administration:
a) Rectal
b) Oral
c) Sublingual
d) Inhalation
015. Parenteral administration:
a) Cannot be used with unconsciousness patients
b) Generally results in a less accurate dosage than oral administration
c) Usually produces a more rapid response than oral administration
d) Is too slow for emergency use
016. What is characteristic of the intramuscular route of drug administration?
a) Only water solutions can be injected
b) Oily solutions can be injected
c) Opportunity of hypertonic solution injections
d) The action develops slower, than at oral administration
017. Intravenous injections are more suitable for oily solutions:
a) True
b) False
018. Correct statements listing characteristics of a particular route of drug administration include all of the following EXCEPT:
a) Intravenous administration provides a rapid response
b) Intramuscular administration requires a sterile technique
c) Inhalation provides slow access to the general circulation
d) Subcutaneous administration may cause local irritation
019. Most of drugs are distributed homogeneously.
a) True
b) False
020. Biological barriers include all except:
a) Renal tubules
b) Cell membranes
c) Capillary walls
d) Placenta
021. What is the reason of complicated penetration of some drugs through brain-blood barrier?
a) High lipid solubility of a drug
b) Meningitis
c) Absence of pores in the brain capillary endothelium
d) High endocytosis degree in a brain capillary
022. The volume of distribution (Vd) relates:
a) Single to a daily dose of an administrated drug
b) An administrated dose to a body weight
c) An uncharged drug reaching the systemic circulation
d) The amount of a drug in the body to the concentration of a drug in plasma
023. For the calculation of the volume of distribution (Vd) one must take into account:
a) Concentration of a substance in plasma
b) Concentration of substance in urine
c) Therapeutical width of drug action
d) A daily dose of drug
024. A small amount of the volume of distribution is common for lipophylic substances easy penetrating through barriers and
widely distributing in plasma, interstitial and cell fluids:

, 7
a) True
b) False
025. The term “biotransformation” includes the following:
a) Accumulation of substances in a fat tissue
b) Binding of substances with plasma proteins
c) Accumulation of substances in a tissue
d) Process of physicochemical and biochemical alteration of a drug in the body
026. Biotransformation of the drugs is to render them:
a) Less ionized
b) More pharmacologically active
c) More lipid soluble
d) Less lipid soluble
027. Tick the drug type for which microsomal oxidation is the most prominent:
a) Lipid soluble
b) Water soluble
c) Low molecular weight
d) High molecular weight
028. Pick out the right statement:
a) Microsomal oxidation always results in inactivation of a compound
b) Microsomal oxidation results in a decrease of compound toxicity
c) Microsomal oxidation results in an increase of ionization and water solubility of a drug
d) Microsomal oxidation results in an increase of lipid solubility of a drug thus its excretion from the organism is facilitated
029. Stimulation of liver microsomal enzymes can:
a) Require the dose increase of some drugs
b) Require the dose decrease of some drugs
c) Prolong the duration of the action of a drug
d) Intensify the unwanted reaction of a drug
030. Metabolic transformation (phase 1) is:
a) Acetylation and methylation of substances
b) Transformation of substances due to oxidation, reduction or hydrolysis
c) Glucuronide formation
d) Binding to plasma proteins
031. Biotransformation of a medicinal substance results in:
a) Faster urinary excretion
b) Slower urinary excretion
c) Easier distribution in organism
d) Higher binding to membranes
032. Conjugation is:
a) Process of drug reduction by special enzymes
b) Process of drug oxidation by special oxidases
c) Coupling of a drug with an endogenous substrate
d) Solubilization in lipids
033. Which of the following processes proceeds in the second phase of biotransformation?
a) Acetylation
b) Reduction
c) Oxidation
d) Hydrolysis
034. Conjugation of a drug includes the following EXCEPT:
a) Glucoronidation
b) Sulfate formation
c) Hydrolysis
d) Methylation
035. Metabolic transformation and conjugation usually results in an increase of a substance biological activity:
a) True
b) False
036. In case of liver disorders accompanied by a decline in microsomal enzyme activity the duration of action of some drugs
is:
a) Decreased
b) Enlarged
c) Remained unchanged
d) Changed insignificantly

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller stuuviaa. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for CA$11.51. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

73918 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
CA$11.51
  • (1)
  Add to cart